Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

L‐DOPA for Parkinson's disease—a bittersweet pill
Emma L. Lane
European Journal of Neuroscience (2018) Vol. 49, Iss. 3, pp. 384-398
Open Access | Times Cited: 58

Showing 26-50 of 58 citing articles:

Mild traumatic brain injury exacerbates Parkinson's disease induced hemeoxygenase-2 expression and brain pathology: Neuroprotective effects of co-administration of TiO2 nanowired mesenchymal stem cells and cerebrolysin
Aruna Sharma, Dafin F. Mureşanu, Ala Nozari, et al.
Progress in brain research (2020), pp. e5-e6
Closed Access | Times Cited: 23
Dopaminergic co-transmission with sonic hedgehog inhibits abnormal involuntary movements in models of Parkinson’s disease and L-Dopa induced dyskinesia
Lauren Malave, Dustin R. Zuelke, Santiago Uribe‐Cano, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 17
Human Embryonic Stem Cell-Derived Dopaminergic Grafts Alleviate L-DOPA Induced Dyskinesia
Osama F. Elabi, Rachel Pass, Irene Sormonta, et al.
Journal of Parkinson s Disease (2022) Vol. 12, Iss. 6, pp. 1881-1896
Open Access | Times Cited: 12
Levodopa Rescues Retinal Function in the Transgenic A53T Alpha-Synuclein Model of Parkinson’s Disease
Katie K. N. Tran, Vickie Wong, Kirstan A. Vessey, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 130-130
Open Access | Times Cited: 2
Role of 5-HT1A Receptor in Vilazodone-Mediated Suppression of L-DOPA-Induced Dyskinesia and Increased Responsiveness to Cortical Input in Striatal Medium Spiny Neurons in an Animal Model of Parkinson’s Disease
Feras Altwal, Fernando E. Padovan‐Neto, Alexandra C. Ritger, et al.
Molecules (2021) Vol. 26, Iss. 19, pp. 5790-5790
Open Access | Times Cited: 15
The Design and Application of an Appropriate Parkinson’s Disease Animal Model in Regenerative Medicine
Bagher Larijani, Parisa Goodarzi, Moloud Payab, et al.
Advances in experimental medicine and biology (2019), pp. 89-105
Closed Access | Times Cited: 16
PT320, Sustained-Release Exendin-4, Mitigates L-DOPA-Induced Dyskinesia in a Rat 6-Hydroxydopamine Model of Parkinson’s Disease
Seong-Jin Yu, Shuchun Chen, Yung-Yung Yang, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 16
Non-Invasive, Targeted Nanoparticle-Mediated Drug Delivery across a Novel Human BBB Model
Shona Kaya, John F. Callan, Susan Hawthorne
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1382-1382
Open Access | Times Cited: 5
L-DOPA-Induced Dyskinesia in a Genetic Drosophila Model of Parkinson's Disease
Joshua A. Blosser, Eric Podolsky, Daewoo Lee
Experimental Neurobiology (2020) Vol. 29, Iss. 4, pp. 273-284
Open Access | Times Cited: 14
Microbiota-mediated effects of Parkinson’s disease medications on Parkinsonian non-motor symptoms in male transgenic mice
Nina Radisavljevic, Avril Metcalfe‐Roach, Mihai Cirstea, et al.
mSphere (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Novel Therapeutic Horizons: SNCA Targeting in Parkinson’s Disease
Alessio Maria Caramiello, Valentina Pirota
Biomolecules (2024) Vol. 14, Iss. 8, pp. 949-949
Open Access | Times Cited: 1
Spermine-Related DNA Hypermethylation and Elevated Expression of Genes for Collagen Formation are Susceptible Factors for Chemotherapy-Induced Hand-Foot Syndrome in Chinese Colorectal Cancer Patients
Mingming Li, Jiani Chen, Shaoqun Liu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 10
Transcriptional Profiling Reveals Brain Region-Specific Gene Networks Regulated in Exercise in a Mouse Model of Parkinson’s Disease
Weifang Tong, Kunshan Zhang, Hongkai Yao, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 7
Opicapone in Uk Clinical Practice: effectiveness, Safety and Cost Analysis in Patients With Parkinson’s Disease
Christine Schofield, К. Ray Chaudhuri, Camille Carroll, et al.
Neurodegenerative Disease Management (2022) Vol. 12, Iss. 2, pp. 77-91
Open Access | Times Cited: 5
Therapeutic Approaches to Non-Motor Symptoms of Parkinson's Disease: A Current Update on Preclinical Evidence
Poornima D. E. Weerasinghe-Mudiyanselage, Sohi Kang, Joong‐Sun Kim, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 3, pp. 560-577
Open Access | Times Cited: 5
Degradation of pyrimidine glycosides and L-DOPA in the faba bean by Rhizopus oligosporus
Katarzyna Polanowska, Artur Szwengiel, Maciej Kuligowski, et al.
LWT (2020) Vol. 127, pp. 109353-109353
Open Access | Times Cited: 6
Transaminase-mediated synthesis of enantiopure drug-like 1-(3′,4′-disubstituted phenyl)propan-2-amines
Ágnes Lakó, Zsófia Molnár, Ricardo Mendonça, et al.
RSC Advances (2020) Vol. 10, Iss. 67, pp. 40894-40903
Open Access | Times Cited: 6
Effects of levodopa on gut bacterial antibiotic resistance in Parkinson’s disease rat
Shuo Sheng, Xianwei Li, Shuo Zhao, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 2
Rapid synthesis of microwave-assisted zinc oxide nanorods on a paper-based analytical device for fluorometric detection of l-dopa
Yu‐Hsuan Lin, Yi-Chun Yeh
Colloids and Surfaces B Biointerfaces (2021) Vol. 207, pp. 111995-111995
Closed Access | Times Cited: 5
Reduced Plasma Levodopa Fluctuations with More Frequent Administration of a Novel Carbidopa/Levodopa Functionally Scored Tablet
Thomas N. Chase, Ahmad Al‐Sabbagh, Minako Koga, et al.
Clinical Pharmacology in Drug Development (2024) Vol. 13, Iss. 4, pp. 380-388
Open Access
Peripheral mast cells derive the effects of acupuncture in Parkinson’s disease
Ju‐Young Oh, Sun-Jeong Bae, Jeong-Yeon Ji, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access
Research on the Effect of Overexpression of Gpr68 on Dopaminergic Neurons in a Mouse Model of Parkinson's Disease by Pet-Ct Imaging
Gaoming Zhuang
(2024)
Closed Access
Prodrugs for neurodegenerative diseases
Paolo Guglielmi, Arianna Granese, Daniela Secci, et al.
Elsevier eBooks (2024), pp. 265-284
Closed Access
Revealing induced pluripotent stem cells' potential as a better alternative to embryonic stem cells for Parkinson's disease treatment based on single-cell RNA-seq
Sen Zhang, Xing Jiang, Min Yan, et al.
Brazilian Journal of Medical and Biological Research (2024) Vol. 57
Open Access
Distribution of Cleaved SNAP-25 in the Rat Brain, following Unilateral Injection of Botulinum Neurotoxin-A into the Striatum
Friederike Schümann, Oliver Schmitt, Andreas Wree, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1685-1685
Open Access | Times Cited: 1

Scroll to top